Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TherapeuticsMD, Inc. Director's Dealing 2005

Sep 1, 2005

35134_dirs_2005-08-31_cd79186b-234b-4051-8b47-34e29a0276fa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2005-08-31

Reporting Person: JENSEN GERALD L (Director, President, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-08-28 Croff Enterprises Inc Class B Preferred Shares P 75050 $3 Acquired 328241 Direct

Footnotes

F1: Not all of these shares have been delivered. This number represents the total number of shares tendered and not withdrawn as part of the Tender Offer for the Class B Preferred Shares.

F2: This includes 132130 shares held by Jensen Development Comapny which is wholly owned by Gerald L. Jensen. This number also includes the 75,050 shares tendered in the Tender Offer for the Class B Preferred B shares, some of which are not yet delivered.